U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951515) titled 'A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Macular Edema After Retinal Vein Occlusion (MK-8748-006)' on Nov. 16.

Brief Summary: Researchers are looking for new ways to treat macular edema after retinal vein occlusion (ME-RVO). ME-RVO happens when a vein becomes blocked in the retina, the back part of the eye. This blockage causes fluid to leak into the macula, which is the part of the retina that helps to see fine details. The buildup of fluid, called macular edema, can cause blurry vision.

In this trial, researchers want to learn if a trial medicine called MK-8748 can treat ME-RVO. A standard (usual) ...